Immunohistochemical (IHC) analysis of tumor tissues harvested on day 21 demonstrated that TEAD3-KO tumors exhibited reduced epithelial-mesenchymal transition (EMT), characterized by downregulation of N-cadherin and upregulation of E-cadherin (Fig. 3H). The gene discussed is CDH2; the disease is neoplasm.